Click’s Digital Therapeutic Shown To Enhance Clinical Benefit Of Migraine Drugs In Pivotal Trial

 
• By Natasha Barrow
  
Migraine affects more than 37 million adults and is the second leading cause of disability in the US. • Source: Shutterstock
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D